Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.
Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma.
复制标题
DOI:
10.1158/1078-0432.ccr-11-2049
复制
发表时间:
2011-12-15
期刊:
影响因子:
--
通讯作者:
Compton DA
中科院分区:
文献类型:
--
作者:
Bakhoum SF;Danilova OV;Kaur P;Levy NB;Compton DA
The specific role of Chromosomal Instability (CIN) in tumorigenesis has been a matter of conjecture. In part, this is due to the challenge of directly observing chromosome mis-segregation events as well as the inability to distinguish the role of CIN, which consists of increased rates of chromosome mis-segregation, from that of aneuploidy, which is a state of non-diploid chromosome number. Here, we examine the contribution of CIN to the prognosis of patients diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) by directly surveying tumor cells, fixed while undergoing anaphase, for evidence of chromosome mis-segregation. H&E-stained samples from a cohort of 54 patients were used to examine the relationship between frequencies of chromosome mis-segregation and patient prognosis, overall survival, and response to treatment. We show that a two-fold increase in the frequency of chromosome mis-segregation led to a 24% decrease in overall survival and 48% decrease in relapse-free survival after treatment. The hazard ratio of death in patients with increased chromosome mis-segregation was 2.31 and these patients were more likely to present with higher tumor stage, exhibit tumor bone marrow involvement, and receive a higher International Prognostic Index (IPI) score. Increased rates of chromosome mis-segregation in DLBCL substantiate inferior outcome and poor prognosis. This is likely due to increased heterogeneity of tumor cells leading to a larger predilection for adaptation in response to external pressures such as metastasis and drug treatments. We propose that targeting CIN would yield improved prognosis and improved response to chemotherapeutic drugs.